Advancing neurological therapies with Dr Bruce Leuchter
Drug Target Review
FEBRUARY 1, 2024
But commitment to neuroscience drug development is critically important given the significant unmet medical needs and the ways in which patients, caregivers, and families suffer. Historically, what has limited investor interest in funding neurological and psychiatric therapies in development?
Let's personalize your content